Cresco Labs (CRLBF) Deferred Taxes (2020 - 2026)
Cresco Labs (CRLBF) posted Deferred Taxes of -$204000.0 for Q1 2026, up 94.73% on a QoQ basis from -$3.9 million in Q4 2025, and up 56.87% year-over-year from -$130043.1 in Q1 2025.
Cresco Labs (CRLBF) Deferred Taxes (2020 - 2026) Analysis & Trends
Cresco Labs' Deferred Taxes history runs 7 years deep, the most recent figure standing at -$204000.0 for Q1 2026.
- Quarterly Deferred Taxes rose 56.87% year-over-year to -$204000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.4 million (down 114.22% YoY) and the FY2025 annual result came in at -$3.7 million, down 1898.06% from the prior year.
- Deferred Taxes was -$204000.0 for Q1 2026 at Cresco Labs, up from -$3.9 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $23.8 million in Q4 2022 and bottomed at -$7.2 million in Q3 2022.
- A 5-year average of $2.2 million and a median of $305000.0 in 2025 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2023 — Deferred Taxes sank 374.52% — and 2024, when it surged 817.18%.
- Cresco Labs' Deferred Taxes stood at $23.8 million in 2022, then plunged by 66.54% to $8.0 million in 2023, then plunged by 67.09% to $2.6 million in 2024, then sank by 247.86% to -$3.9 million in 2025, then jumped by 94.73% to -$204000.0 in 2026.
- Business Quant data shows CRLBF's Deferred Taxes at -$204000.0 in Q1 2026, -$3.9 million in Q4 2025, and $305000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | -204,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -204,000.00 |
| Dec 31, 2025 | -3.87 Mn |
| Sep 30, 2025 | 305,000.00 |
| Jun 30, 2025 | 332,000.00 |
| Mar 31, 2025 | -473,000.00 |
| Dec 31, 2024 | 2.62 Mn |
| Sep 30, 2024 | 19.02 Mn |
| Jun 30, 2024 | 2.99 Mn |
| Mar 31, 2024 | 941,000.00 |
| Dec 31, 2023 | 7.95 Mn |
| Sep 30, 2023 | -5.75 Mn |
| Jun 30, 2023 | 326,000.00 |
| Mar 31, 2023 | -987,000.00 |
| Dec 31, 2022 | 23.76 Mn |
| Sep 30, 2022 | -7.17 Mn |
| Jun 30, 2022 | -1.68 Mn |
| Mar 31, 2022 | -208,000.00 |
| Dec 31, 2021 | 5.64 Mn |
| Sep 30, 2021 | -28.35 Mn |
| Jun 30, 2021 | -8.73 Mn |